Skip to main content

U.S. Pharmaceutical Sales - Q2 2012

The following is a list of the top 100 prescribed medicines by US National Sales in Q2 2012. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 drugs for Q2 2012 by units sold

Rank Drug Units (000)
1 (1) acetaminophen/hydrocodone
Generic
1.59% Stats
2 (1) budesonide
Generic
-28.55% Stats
3 (2) Singulair
Merck
3.72% Stats
4 (1) ProAir HFA
Teva Pharmaceuticals USA, Inc.
-15.04% Stats
5 (1) OneTouch
-8.93% Stats
6 Nexium
AstraZeneca
-2.05% Stats
7 Cymbalta
2.20% Stats
8 Lantus
Sanofi
-1.72% Stats
9 Advair Diskus
GlaxoSmithKline
-3.10% Stats
10 Ventolin HFA
GlaxoSmithKline
-8.57% Stats
11 (3) atorvastatin
Generic
12.83% Stats
12 (1) Crestor
AstraZeneca
2.80% Stats
13 (2) fentanyl
Generic
7.36% Stats
14 (2) Lantus Solostar
Sanofi
4.82% Stats
15 (2) enoxaparin
Generic
9.75% Stats
16 (4) AndroGel
AbbVie Inc.
-13.78% Stats
17 (1) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc.
0.76% Stats
18 (7) Plavix
-41.53% Stats
19 Novolog
Novo Nordisk
0.91% Stats
20 (1) Levemir
Novo Nordisk
3.02% Stats
21 (1) Nasonex
Merck
-2.48% Stats
22 (1) NovoLog FlexPen
Novo Nordisk
6.67% Stats
23 (2) metoprolol
Generic
7.78% Stats
24 Abilify
Otsuka Pharmaceutical Co., Ltd
0.28% Stats
25 (3) Humalog
Eli Lilly and Company
-4.09% Stats
26 () Synthroid
AbbVie Inc.
n/a Stats
27 (1) Januvia
Merck
3.19% Stats
28 (1) Diovan
Novartis Pharmaceuticals Corporation
-3.43% Stats
29 (1) Namenda
Allergan plc
-2.87% Stats
30 (1) Lyrica
-0.45% Stats
31 Zetia
Merck
-1.69% Stats
32 (4) Symbicort
AstraZeneca
3.51% Stats
33 (2) Suboxone
1.98% Stats
34 (4) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc.
-4.23% Stats
35 (1) Flovent HFA
GlaxoSmithKline
-6.61% Stats
36 (3) Actos
Takeda Pharmaceutical Company Limited
-8.94% Stats
37 (22) escitalopram
Generic
123.42% Stats
38 (1) Remicade
Janssen Pharmaceuticals, Inc.
2.38% Stats
39 (1) Lidoderm
Endo Pharmaceuticals Inc.
1.53% Stats
40 Lovaza
GlaxoSmithKline
0.78% Stats
41 Benicar
Daiichi Sankyo
-1.76% Stats
42 (10) Lipitor
-27.90% Stats
43 Dexilant
Takeda Pharmaceutical Company Limited
3.06% Stats
44 (1) Restasis
Allergan plc
2.79% Stats
45 (2) OxyContin
Purdue Pharma LP
0.16% Stats
46 Diovan HCT
Novartis Pharmaceuticals Corporation
-3.36% Stats
47 (3) Vytorin
Merck
-8.16% Stats
48 (4) VESIcare
Astellas Pharma US, Inc.
3.37% Stats
49 (4) Celebrex
2.25% Stats
50 (1) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc.
-2.77% Stats
51 (3) Janumet
Merck
1.56% Stats
52 (2) Niaspan
AbbVie Inc.
-7.61% Stats
53 (3) Enbrel
Amgen Inc.
6.68% Stats
54 () Evista
n/a Stats
55 TriCor
AbbVie Inc.
-6.85% Stats
56 (2) Vyvanse
Takeda Pharmaceutical Company Limited
-2.78% Stats
57 Aciphex
Eisai Inc.
-3.91% Stats
58 (2) methylphenidate
Generic
-5.19% Stats
59 (2) Cialis
Eli Lilly and Company
5.61% Stats
60 (2) amphetamine/dextroamphetamine
Generic
0.61% Stats
61 (3) Epogen
Amgen Inc.
12.79% Stats
62 (4) Humira
AbbVie Inc.
8.97% Stats
63 (2) Rituxan
Genentech, Inc.
5.30% Stats
64 (1) Truvada
Gilead Sciences, Inc.
-0.52% Stats
65 (2) Rebif
EMD Serono, Inc.
5.93% Stats
66 (3) Atripla
Gilead Sciences, Inc.
-2.45% Stats
67 (3) Avastin
Genentech, Inc.
3.48% Stats
68 (5) Viagra
0.45% Stats
69 () Victoza
Novo Nordisk
n/a Stats
70 (1) Seroquel XR
AstraZeneca
-3.79% Stats
71 () modafinil
Generic
n/a Stats
72 (2) Adderall XR
Takeda Pharmaceutical Company Limited
-10.85% Stats
73 (3) Neulasta
Amgen Inc.
1.21% Stats
74 (1) Lunesta
Sunovion Pharmaceuticals Inc.
-4.02% Stats
75 (3) Orencia
Bristol-Myers Squibb Company
5.10% Stats
76 (3) Procrit
Janssen Pharmaceuticals, Inc.
7.12% Stats
77 () Mirena
Bayer HealthCare Pharmaceuticals Inc.
n/a Stats
78 () Renvela
Sanofi
n/a Stats
79 () Varivax
Merck
n/a Stats
80 Aranesp
Amgen Inc.
-3.75% Stats
81 (2) Eloxatin
Sanofi
2.55% Stats
82 Reyataz
Bristol-Myers Squibb Company
-1.76% Stats
83 (1) Erbitux
Eli Lilly and Company
-1.50% Stats
84 (1) Isentress
Merck
4.10% Stats
85 (48) Seroquel
AstraZeneca
-85.07% Stats
86 (2) Copaxone
Teva Pharmaceuticals USA, Inc.
6.13% Stats
87 (2) Prezista
Janssen Pharmaceuticals, Inc.
5.80% Stats
88 (1) Lucentis
Genentech, Inc.
-4.91% Stats
89 (1) Alimta
Eli Lilly and Company
7.47% Stats
90 (1) Neupogen
Amgen Inc.
4.12% Stats
91 (2) Prevnar 13
Pfizer Inc.
7.74% Stats
92 Herceptin
Genentech, Inc.
5.16% Stats
93 (1) Velcade
Takeda Pharmaceutical Company Limited
8.90% Stats
94 (1) Zyvox
Pfizer Inc.
-2.76% Stats
95 (1) Avonex
Biogen
1.54% Stats
96 (2) Gleevec
Novartis Pharmaceuticals Corporation
6.33% Stats
97 () Xeloda
Genentech, Inc.
n/a Stats
98 (1) Betaseron
Bayer HealthCare Pharmaceuticals Inc.
-11.94% Stats
99 () Gilenya
Novartis Pharmaceuticals Corporation
n/a Stats
100 Incivek
Vertex Pharmaceuticals Incorporated
-8.33% Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.